医学
药物重新定位
疾病
阿尔茨海默病
重新调整用途
药理学
药品
重症监护医学
痴呆
内科学
生物
生态学
作者
Christine Shing Wei Law,Tan Soo Choon
标识
DOI:10.2174/0929867327666200312114223
摘要
Alzheimer’s disease (AD) is a neurodegenerative disorder that has affected millions of people worldwide. However, currently, there is no treatment to cure the disease. The AD drugs available in the market only manage the disease symptomatically and the effects are usually short-term. Thus, there is a need to look at alternatives AD therapies. This literature review aims to shed some light on the potential of repurposing antihypertensives to treat AD. Mid-life hypertension has not only been recognised as a risk factor for AD, but its relation with AD has also been well established. Hence, antihypertensives were postulated to be beneficial in managing AD. Four classes of antihypertensives, as well as their potential limitations and prospects in being utilised as AD therapeutics, were discussed in this review.
科研通智能强力驱动
Strongly Powered by AbleSci AI